ADTX
Aditxt, Inc.
NASDAQ · Healthcare · Biotechnology · US
$0.01
+7.35%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 0.00x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- -0.00x
- Price / sales
- 0.46x
- Price / cash flow
- -0.00x
Enterprise value
- Enterprise value
- $2.1M
- EV / sales
- 144.67x
- EV / EBITDA
- -0.04x
- EV / EBIT
- -0.11x
- Market cap
- $6.6K
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Mar 1, 2026